Hinge Health, Inc. (HNGE)
92.37
+1.61
(+1.77%)
USD |
NYSE |
Sep 04, 16:00
92.24
-0.13
(-0.14%)
Pre-Market: 20:00
Hinge Health SG&A Expense (TTM) : 385.66M for June 30, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 385.66M |
| March 31, 2026 | 674.68M |
| December 31, 2025 | 646.46M |
| September 30, 2025 | 615.25M |
| June 30, 2025 | 574.19M |
| March 31, 2025 | 175.72M |
| December 31, 2024 | 112.12M |
| Date | Value |
|---|---|
| September 30, 2024 | 59.32M |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| West Pharmaceutical Services, Inc. | 426.80M |
| Vivos Therapeutics, Inc. | 33.70M |
| Exlites Holdings International, Inc. | 0.1111M |
| Xcelerate, Inc. | 0.0698M |
| Globus Medical, Inc. | 1.217B |